Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN358711 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Neuregulin 1 (NRG1) (Middle Region) antibody
- Antibody type
- Polyclonal
- Description
- Protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- Middle Region
- Vial size
- 0.4 mL
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at-20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references The heregulin/human epidermal growth factor receptor as a new growth factor system in melanoma with multiple ways of deregulation.
Segregation of receptor and ligand regulates activation of epithelial growth factor receptor.
Neuregulin-1 enhances motility and migration of human astrocytic glioma cells.
Heregulin is sufficient for the promotion of tumorigenicity and metastasis of breast cancer cells in vivo.
A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRG1 gene.
Stove C, Stove V, Derycke L, Van Marck V, Mareel M, Bracke M
The Journal of investigative dermatology 2003 Oct;121(4):802-12
The Journal of investigative dermatology 2003 Oct;121(4):802-12
Segregation of receptor and ligand regulates activation of epithelial growth factor receptor.
Vermeer PD, Einwalter LA, Moninger TO, Rokhlina T, Kern JA, Zabner J, Welsh MJ
Nature 2003 Mar 20;422(6929):322-6
Nature 2003 Mar 20;422(6929):322-6
Neuregulin-1 enhances motility and migration of human astrocytic glioma cells.
Ritch PA, Carroll SL, Sontheimer H
The Journal of biological chemistry 2003 Jun 6;278(23):20971-8
The Journal of biological chemistry 2003 Jun 6;278(23):20971-8
Heregulin is sufficient for the promotion of tumorigenicity and metastasis of breast cancer cells in vivo.
Atlas E, Cardillo M, Mehmi I, Zahedkargaran H, Tang C, Lupu R
Molecular cancer research : MCR 2003 Jan;1(3):165-75
Molecular cancer research : MCR 2003 Jan;1(3):165-75
A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRG1 gene.
Adélaïde J, Huang HE, Murati A, Alsop AE, Orsetti B, Mozziconacci MJ, Popovici C, Ginestier C, Letessier A, Basset C, Courtay-Cahen C, Jacquemier J, Theillet C, Birnbaum D, Edwards PA, Chaffanet M
Genes, chromosomes & cancer 2003 Aug;37(4):333-45
Genes, chromosomes & cancer 2003 Aug;37(4):333-45
No comments: Submit comment
No validations: Submit validation data